UCL Department of Biochemical Engineering


Vax-Hub Awarded £2m and Extended to 2023

7 April 2022

We are pleased to announce that following an application and interview process, Vax-Hub has been awarded £2 million to extend its work until 31 March 2023

Image of hand with vax hub logo imposed over top

The funding from the Department of Health and Social Care (DHSC) and managed by the Engineering and Physical Sciences Research Council (EPSRC), will enable the Hub to continue its research to enhance vaccine manufacturing globally, with the primary aim of improving access to essential vaccines in low-resource settings. Work packages will focus on GMP readiness, platform manufacturing, analytics, and formulation.   
Hub Co-Director, Professor Martina Micheletti said: “This is great news! The new funding will allow Vax-Hub to progress its vision to make the UK the global centre for integrated discovery through to manufacture of next generation vaccines and to meet new goals in technology discovery and alternative vaccine delivery routes. The Vax-Hub team welcomes new PIs from the University of Leeds, the Oxford Jenner Institute and the UCL School of Pharmacy.”